Marijuana use increased during COVID-19 lockdown, survey shows

The coronavirus pandemic led to a decrease in the use of party drugs like MDMA and cocaine, but also to an increase in pot use, according to Global Drug Survey.

Forty thousand people from 12 countries participated in the online survey that looked at changes in alcohol and drug-related habits during the global health crisis. The 12 countries included in the study were Germany, France, the Netherlands, New Zealand, Ireland, Australia, the United Kingdom, Austria, Denmark, Greece, Brazil, and Switzerland. 

Based on the data, nearly a fifth of people reported that they used less cocaine during lockdown, while 29% said they used less MDMA, popularly known as ecstasy or molly. 


Swiss government wants to ease access to medical marijuana

The Swiss government wants to empower doctors to prescribe cannabis for medical purposes without authorisation. On Wednesday, the Federal Council submitted a revised version of the narcotics law to parliament for deliberation.

Cannabis, whether for recreational or medical purposes, has been banned in Switzerland since 1951. However, doctors may prescribe a medicine based on this substance if they get an exceptional green light from the Federal Office of Public Health.

But the government believes this process complicates access to treatment, delays the start of therapies and is no longer adequate in view of the growing number of requests.


Cannabis Distribution Scheme Guidelines Approved in Switzerland

Switzerland’s National Council has announced its agreement with guidelines set out for a study of a recreational cannabis distribution scheme. The scheme will aim to assess the potential effects of a system of controlled recreational cannabis use in the country. 


What’s the Deal with Organic Regulation for Cannabis?

While the standard consumer might not be contemplating whether their CBD oil, hemp flower, or cannabis edible came from an organic source, there is more and more push for better regulatory standards in general, and for organic as well.

Now, let’s talk a little bit about pesticides…


Switzerland Unofficially Launches Cannabis Pilot, What’s Next?

Unlike France’s upcoming cannabis trial, Switzerland will be pursuing an altogether more ambitious project. Though the Swiss government would monitor a larger number of users, the pilot will test the viability of legalising recreational cannabis in Switzerland.

Related: How Germany’s Hemp Association Fights Cannabis Criminalisation

Indeed, the stakes are much higher — but, if successful, Europe could expect an immediate regulatory windfall.


Davos cannabis conclave advances cause for legalisation

The second annual, premier cannabis industry event – the Cannabis Conclave – returned to Davos this January to bring together industry leaders and policy makers.

This year the Cannabis Conclave brought together cannabis industry executives, global investors, policy makers and international media to fuel the legalisation debate globally, both for recreational and medical cannabis, and to highlight the growing legitimacy and maturity of the legal cannabis industry.


Swiss cannabis market worth up to half a billion francs annually

Cannabis remains by far the most widespread drug enjoyed in Switzerland, even if the value of the market is much lower than that for cocaine, researchers have found.

A study publishedexternal link Thursday by several groups including Addiction Switzerland estimates the national cannabis market to be worth up to CHF500 million ($516 million).

But in canton Vaud, where the study was carried out, the figures show that the total market value was around half that of for cocaine – a finding that Frank Zobel, co-director of Addiction Switzerland, said was a surprise.


Cannabis House at Davos 2020 to tackle climate change, sustainability, healthcare

In a show of the growing acceptance of the pot industry, the World Economic Forum in Davos will host the Cannabis House for the second year in a row this week.

Top cannabis industry executives will flock to the small Swiss town for a two-day conference at the Cannabis House hosted by CannTech.

Discussions will aim to highlight “the economic role of cannabis in the future of healthcare, international trade, investment, and environmental and resource security, with the goal of creating a fair and viable cannabis-related industry globally.”


Pot industry heads to Davos as stocks rebound

Tough times in the cannabis industry aren’t stopping its leaders from going to Davos.

For the second year in a row, there will be a Cannabis House in Davos, Switzerland this week alongside the schmoozing and speeches of the World Economic Forum. The 2020 offering promises to be “a little more formal and more professional” than last year’s, according to Jason Paltrowitz, executive vice president of corporate services at OTC Markets Group, one of the sponsors of the Cannabis House.

Cannabis House will feature a two-day conference focused on the themes of Davos 2020, including sustainability, climate change, social equity and impact investing.


Can Medical Marijuana Help Aging parents with dementia?

For decades, marijuana, even for medical uses, was demonized or questioned.  When states like Colorado legalized it for recreational use, more studies began to determine provable efficacy for its use as a medicine. The Federal government still classifies marijuana the same way it classifies heroin: harmful and with no medical benefits. Now we can see that this is wrong. When states legalized marijuana, referred to as cannabis here, they had an interest in getting data to see what good it could do. Proving efficacy could increase medical marijuana sales, benefit people who might at least find some medical use, and overall would bring tax dollars into the state coffers.


Subscribe to RSS - Switzerland